CXXI — C21 Investments Income Statement
0.000.00%
Last trade - 00:00
- CA$41.42m
- CA$40.39m
- $28.89m
- 43
- 87
- 19
- 47
2019 January 31st | 2020 January 31st | R2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.59 | 37.7 | 33.5 | 33 | 28.9 |
Cost of Revenue | |||||
Gross Profit | 0.183 | 13.3 | 18 | 18.8 | 13.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 24.7 | 67.3 | 24.2 | 23.2 | 25 |
Operating Profit | -22.2 | -29.6 | 9.24 | 9.75 | 3.93 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -23.6 | -28.8 | -1.63 | 17.1 | 4.19 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23.6 | -32.6 | -4.6 | 13.2 | 1.38 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -23.6 | -32.6 | -7.83 | 10.9 | 0.293 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.6 | -32.6 | -7.83 | 10.9 | 0.293 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.431 | -0.184 | -0.044 | 0.11 | 0.017 |